0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Canine Cancer Screening Market Research Report 2024
Published Date: September 2024
|
Report Code: QYRE-Auto-23Z17950
Home | Market Reports | Pets & Animals| Animal Products & Services| Veterinarians
Global Canine Cancer Screening Market Research Report 2024
BUY CHAPTERS

Global Canine Cancer Screening Market Research Report 2024

Code: QYRE-Auto-23Z17950
Report
September 2024
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Canine Cancer Screening Market

Canine cancer screening is a process used to detect cancer in dogs at an early stage, often before symptoms become noticeable. Early detection can significantly improve the chances of successful treatment. Screening methods may include blood tests, imaging (such as X-rays or ultrasounds), and physical exams. Recently, there has also been progress in genetic testing and liquid biopsy techniques, which involve detecting cancer-related DNA or biomarkers in a dog's blood sample.
The global Canine Cancer Screening market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Canine Cancer Screening is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Canine Cancer Screening is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Canine Cancer Screening in Veterinary Clinics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Canine Cancer Screening include IDEXX, Mars Pedtcare, Zoetis, PetDx, Molecular Diagnostics (MDxHealth), Biomérieux SA, OncoK9, Antech Diagnostics, VolitionRx Limited, Oncotect, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Canine Cancer Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Canine Cancer Screening.
The Canine Cancer Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Canine Cancer Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Canine Cancer Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Canine Cancer Screening Market Report

Report Metric Details
Report Name Canine Cancer Screening Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company IDEXX, Mars Pedtcare, Zoetis, PetDx, Molecular Diagnostics (MDxHealth), Biomérieux SA, OncoK9, Antech Diagnostics, VolitionRx Limited, Oncotect, Heska Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Canine Cancer Screening company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Canine Cancer Screening Market report?

Ans: The main players in the Canine Cancer Screening Market are IDEXX, Mars Pedtcare, Zoetis, PetDx, Molecular Diagnostics (MDxHealth), Biomérieux SA, OncoK9, Antech Diagnostics, VolitionRx Limited, Oncotect, Heska Corporation

What are the Application segmentation covered in the Canine Cancer Screening Market report?

Ans: The Applications covered in the Canine Cancer Screening Market report are Veterinary Clinics, Veterinary Hospitals, Other

What are the Type segmentation covered in the Canine Cancer Screening Market report?

Ans: The Types covered in the Canine Cancer Screening Market report are Liquid Biopsy (Blood-Based Tests), Tissue Biopsy, Genomic Testing, Biomarker Tests

Recommended Reports

Veterinary Diagnostics

Veterinary Imaging

Pet Health Supplements

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Canine Cancer Screening Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Liquid Biopsy (Blood-Based Tests)
1.2.3 Tissue Biopsy
1.2.4 Genomic Testing
1.2.5 Biomarker Tests
1.3 Market by Application
1.3.1 Global Canine Cancer Screening Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Veterinary Clinics
1.3.3 Veterinary Hospitals
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Canine Cancer Screening Market Perspective (2019-2030)
2.2 Global Canine Cancer Screening Growth Trends by Region
2.2.1 Global Canine Cancer Screening Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Canine Cancer Screening Historic Market Size by Region (2019-2024)
2.2.3 Canine Cancer Screening Forecasted Market Size by Region (2025-2030)
2.3 Canine Cancer Screening Market Dynamics
2.3.1 Canine Cancer Screening Industry Trends
2.3.2 Canine Cancer Screening Market Drivers
2.3.3 Canine Cancer Screening Market Challenges
2.3.4 Canine Cancer Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Canine Cancer Screening Players by Revenue
3.1.1 Global Top Canine Cancer Screening Players by Revenue (2019-2024)
3.1.2 Global Canine Cancer Screening Revenue Market Share by Players (2019-2024)
3.2 Global Canine Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Canine Cancer Screening Revenue
3.4 Global Canine Cancer Screening Market Concentration Ratio
3.4.1 Global Canine Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Canine Cancer Screening Revenue in 2023
3.5 Global Key Players of Canine Cancer Screening Head office and Area Served
3.6 Global Key Players of Canine Cancer Screening, Product and Application
3.7 Global Key Players of Canine Cancer Screening, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Canine Cancer Screening Breakdown Data by Type
4.1 Global Canine Cancer Screening Historic Market Size by Type (2019-2024)
4.2 Global Canine Cancer Screening Forecasted Market Size by Type (2025-2030)
5 Canine Cancer Screening Breakdown Data by Application
5.1 Global Canine Cancer Screening Historic Market Size by Application (2019-2024)
5.2 Global Canine Cancer Screening Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Canine Cancer Screening Market Size (2019-2030)
6.2 North America Canine Cancer Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Canine Cancer Screening Market Size by Country (2019-2024)
6.4 North America Canine Cancer Screening Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Canine Cancer Screening Market Size (2019-2030)
7.2 Europe Canine Cancer Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Canine Cancer Screening Market Size by Country (2019-2024)
7.4 Europe Canine Cancer Screening Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Canine Cancer Screening Market Size (2019-2030)
8.2 Asia-Pacific Canine Cancer Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Canine Cancer Screening Market Size by Region (2019-2024)
8.4 Asia-Pacific Canine Cancer Screening Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Canine Cancer Screening Market Size (2019-2030)
9.2 Latin America Canine Cancer Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Canine Cancer Screening Market Size by Country (2019-2024)
9.4 Latin America Canine Cancer Screening Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Canine Cancer Screening Market Size (2019-2030)
10.2 Middle East & Africa Canine Cancer Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Canine Cancer Screening Market Size by Country (2019-2024)
10.4 Middle East & Africa Canine Cancer Screening Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IDEXX
11.1.1 IDEXX Company Details
11.1.2 IDEXX Business Overview
11.1.3 IDEXX Canine Cancer Screening Introduction
11.1.4 IDEXX Revenue in Canine Cancer Screening Business (2019-2024)
11.1.5 IDEXX Recent Development
11.2 Mars Pedtcare
11.2.1 Mars Pedtcare Company Details
11.2.2 Mars Pedtcare Business Overview
11.2.3 Mars Pedtcare Canine Cancer Screening Introduction
11.2.4 Mars Pedtcare Revenue in Canine Cancer Screening Business (2019-2024)
11.2.5 Mars Pedtcare Recent Development
11.3 Zoetis
11.3.1 Zoetis Company Details
11.3.2 Zoetis Business Overview
11.3.3 Zoetis Canine Cancer Screening Introduction
11.3.4 Zoetis Revenue in Canine Cancer Screening Business (2019-2024)
11.3.5 Zoetis Recent Development
11.4 PetDx
11.4.1 PetDx Company Details
11.4.2 PetDx Business Overview
11.4.3 PetDx Canine Cancer Screening Introduction
11.4.4 PetDx Revenue in Canine Cancer Screening Business (2019-2024)
11.4.5 PetDx Recent Development
11.5 Molecular Diagnostics (MDxHealth)
11.5.1 Molecular Diagnostics (MDxHealth) Company Details
11.5.2 Molecular Diagnostics (MDxHealth) Business Overview
11.5.3 Molecular Diagnostics (MDxHealth) Canine Cancer Screening Introduction
11.5.4 Molecular Diagnostics (MDxHealth) Revenue in Canine Cancer Screening Business (2019-2024)
11.5.5 Molecular Diagnostics (MDxHealth) Recent Development
11.6 Biomérieux SA
11.6.1 Biomérieux SA Company Details
11.6.2 Biomérieux SA Business Overview
11.6.3 Biomérieux SA Canine Cancer Screening Introduction
11.6.4 Biomérieux SA Revenue in Canine Cancer Screening Business (2019-2024)
11.6.5 Biomérieux SA Recent Development
11.7 OncoK9
11.7.1 OncoK9 Company Details
11.7.2 OncoK9 Business Overview
11.7.3 OncoK9 Canine Cancer Screening Introduction
11.7.4 OncoK9 Revenue in Canine Cancer Screening Business (2019-2024)
11.7.5 OncoK9 Recent Development
11.8 Antech Diagnostics
11.8.1 Antech Diagnostics Company Details
11.8.2 Antech Diagnostics Business Overview
11.8.3 Antech Diagnostics Canine Cancer Screening Introduction
11.8.4 Antech Diagnostics Revenue in Canine Cancer Screening Business (2019-2024)
11.8.5 Antech Diagnostics Recent Development
11.9 VolitionRx Limited
11.9.1 VolitionRx Limited Company Details
11.9.2 VolitionRx Limited Business Overview
11.9.3 VolitionRx Limited Canine Cancer Screening Introduction
11.9.4 VolitionRx Limited Revenue in Canine Cancer Screening Business (2019-2024)
11.9.5 VolitionRx Limited Recent Development
11.10 Oncotect
11.10.1 Oncotect Company Details
11.10.2 Oncotect Business Overview
11.10.3 Oncotect Canine Cancer Screening Introduction
11.10.4 Oncotect Revenue in Canine Cancer Screening Business (2019-2024)
11.10.5 Oncotect Recent Development
11.11 Heska Corporation
11.11.1 Heska Corporation Company Details
11.11.2 Heska Corporation Business Overview
11.11.3 Heska Corporation Canine Cancer Screening Introduction
11.11.4 Heska Corporation Revenue in Canine Cancer Screening Business (2019-2024)
11.11.5 Heska Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Canine Cancer Screening Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Liquid Biopsy (Blood-Based Tests)
 Table 3. Key Players of Tissue Biopsy
 Table 4. Key Players of Genomic Testing
 Table 5. Key Players of Biomarker Tests
 Table 6. Global Canine Cancer Screening Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Canine Cancer Screening Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 8. Global Canine Cancer Screening Market Size by Region (2019-2024) & (US$ Million)
 Table 9. Global Canine Cancer Screening Market Share by Region (2019-2024)
 Table 10. Global Canine Cancer Screening Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 11. Global Canine Cancer Screening Market Share by Region (2025-2030)
 Table 12. Canine Cancer Screening Market Trends
 Table 13. Canine Cancer Screening Market Drivers
 Table 14. Canine Cancer Screening Market Challenges
 Table 15. Canine Cancer Screening Market Restraints
 Table 16. Global Canine Cancer Screening Revenue by Players (2019-2024) & (US$ Million)
 Table 17. Global Canine Cancer Screening Market Share by Players (2019-2024)
 Table 18. Global Top Canine Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Cancer Screening as of 2023)
 Table 19. Ranking of Global Top Canine Cancer Screening Companies by Revenue (US$ Million) in 2023
 Table 20. Global 5 Largest Players Market Share by Canine Cancer Screening Revenue (CR5 and HHI) & (2019-2024)
 Table 21. Global Key Players of Canine Cancer Screening, Headquarters and Area Served
 Table 22. Global Key Players of Canine Cancer Screening, Product and Application
 Table 23. Global Key Players of Canine Cancer Screening, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Canine Cancer Screening Market Size by Type (2019-2024) & (US$ Million)
 Table 26. Global Canine Cancer Screening Revenue Market Share by Type (2019-2024)
 Table 27. Global Canine Cancer Screening Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 28. Global Canine Cancer Screening Revenue Market Share by Type (2025-2030)
 Table 29. Global Canine Cancer Screening Market Size by Application (2019-2024) & (US$ Million)
 Table 30. Global Canine Cancer Screening Revenue Market Share by Application (2019-2024)
 Table 31. Global Canine Cancer Screening Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 32. Global Canine Cancer Screening Revenue Market Share by Application (2025-2030)
 Table 33. North America Canine Cancer Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 34. North America Canine Cancer Screening Market Size by Country (2019-2024) & (US$ Million)
 Table 35. North America Canine Cancer Screening Market Size by Country (2025-2030) & (US$ Million)
 Table 36. Europe Canine Cancer Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 37. Europe Canine Cancer Screening Market Size by Country (2019-2024) & (US$ Million)
 Table 38. Europe Canine Cancer Screening Market Size by Country (2025-2030) & (US$ Million)
 Table 39. Asia-Pacific Canine Cancer Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 40. Asia-Pacific Canine Cancer Screening Market Size by Region (2019-2024) & (US$ Million)
 Table 41. Asia-Pacific Canine Cancer Screening Market Size by Region (2025-2030) & (US$ Million)
 Table 42. Latin America Canine Cancer Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. Latin America Canine Cancer Screening Market Size by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Canine Cancer Screening Market Size by Country (2025-2030) & (US$ Million)
 Table 45. Middle East & Africa Canine Cancer Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 46. Middle East & Africa Canine Cancer Screening Market Size by Country (2019-2024) & (US$ Million)
 Table 47. Middle East & Africa Canine Cancer Screening Market Size by Country (2025-2030) & (US$ Million)
 Table 48. IDEXX Company Details
 Table 49. IDEXX Business Overview
 Table 50. IDEXX Canine Cancer Screening Product
 Table 51. IDEXX Revenue in Canine Cancer Screening Business (2019-2024) & (US$ Million)
 Table 52. IDEXX Recent Development
 Table 53. Mars Pedtcare Company Details
 Table 54. Mars Pedtcare Business Overview
 Table 55. Mars Pedtcare Canine Cancer Screening Product
 Table 56. Mars Pedtcare Revenue in Canine Cancer Screening Business (2019-2024) & (US$ Million)
 Table 57. Mars Pedtcare Recent Development
 Table 58. Zoetis Company Details
 Table 59. Zoetis Business Overview
 Table 60. Zoetis Canine Cancer Screening Product
 Table 61. Zoetis Revenue in Canine Cancer Screening Business (2019-2024) & (US$ Million)
 Table 62. Zoetis Recent Development
 Table 63. PetDx Company Details
 Table 64. PetDx Business Overview
 Table 65. PetDx Canine Cancer Screening Product
 Table 66. PetDx Revenue in Canine Cancer Screening Business (2019-2024) & (US$ Million)
 Table 67. PetDx Recent Development
 Table 68. Molecular Diagnostics (MDxHealth) Company Details
 Table 69. Molecular Diagnostics (MDxHealth) Business Overview
 Table 70. Molecular Diagnostics (MDxHealth) Canine Cancer Screening Product
 Table 71. Molecular Diagnostics (MDxHealth) Revenue in Canine Cancer Screening Business (2019-2024) & (US$ Million)
 Table 72. Molecular Diagnostics (MDxHealth) Recent Development
 Table 73. Biomérieux SA Company Details
 Table 74. Biomérieux SA Business Overview
 Table 75. Biomérieux SA Canine Cancer Screening Product
 Table 76. Biomérieux SA Revenue in Canine Cancer Screening Business (2019-2024) & (US$ Million)
 Table 77. Biomérieux SA Recent Development
 Table 78. OncoK9 Company Details
 Table 79. OncoK9 Business Overview
 Table 80. OncoK9 Canine Cancer Screening Product
 Table 81. OncoK9 Revenue in Canine Cancer Screening Business (2019-2024) & (US$ Million)
 Table 82. OncoK9 Recent Development
 Table 83. Antech Diagnostics Company Details
 Table 84. Antech Diagnostics Business Overview
 Table 85. Antech Diagnostics Canine Cancer Screening Product
 Table 86. Antech Diagnostics Revenue in Canine Cancer Screening Business (2019-2024) & (US$ Million)
 Table 87. Antech Diagnostics Recent Development
 Table 88. VolitionRx Limited Company Details
 Table 89. VolitionRx Limited Business Overview
 Table 90. VolitionRx Limited Canine Cancer Screening Product
 Table 91. VolitionRx Limited Revenue in Canine Cancer Screening Business (2019-2024) & (US$ Million)
 Table 92. VolitionRx Limited Recent Development
 Table 93. Oncotect Company Details
 Table 94. Oncotect Business Overview
 Table 95. Oncotect Canine Cancer Screening Product
 Table 96. Oncotect Revenue in Canine Cancer Screening Business (2019-2024) & (US$ Million)
 Table 97. Oncotect Recent Development
 Table 98. Heska Corporation Company Details
 Table 99. Heska Corporation Business Overview
 Table 100. Heska Corporation Canine Cancer Screening Product
 Table 101. Heska Corporation Revenue in Canine Cancer Screening Business (2019-2024) & (US$ Million)
 Table 102. Heska Corporation Recent Development
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Canine Cancer Screening Picture
 Figure 2. Global Canine Cancer Screening Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Canine Cancer Screening Market Share by Type: 2023 VS 2030
 Figure 4. Liquid Biopsy (Blood-Based Tests) Features
 Figure 5. Tissue Biopsy Features
 Figure 6. Genomic Testing Features
 Figure 7. Biomarker Tests Features
 Figure 8. Global Canine Cancer Screening Market Size by Application (2024-2030) & (US$ Million)
 Figure 9. Global Canine Cancer Screening Market Share by Application: 2023 VS 2030
 Figure 10. Veterinary Clinics Case Studies
 Figure 11. Veterinary Hospitals Case Studies
 Figure 12. Other Case Studies
 Figure 13. Canine Cancer Screening Report Years Considered
 Figure 14. Global Canine Cancer Screening Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 15. Global Canine Cancer Screening Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 16. Global Canine Cancer Screening Market Share by Region: 2023 VS 2030
 Figure 17. Global Canine Cancer Screening Market Share by Players in 2023
 Figure 18. Global Top Canine Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Cancer Screening as of 2023)
 Figure 19. The Top 10 and 5 Players Market Share by Canine Cancer Screening Revenue in 2023
 Figure 20. North America Canine Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. North America Canine Cancer Screening Market Share by Country (2019-2030)
 Figure 22. United States Canine Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Canada Canine Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Canine Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. Europe Canine Cancer Screening Market Share by Country (2019-2030)
 Figure 26. Germany Canine Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. France Canine Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. U.K. Canine Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Italy Canine Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Russia Canine Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Nordic Countries Canine Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Canine Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Asia-Pacific Canine Cancer Screening Market Share by Region (2019-2030)
 Figure 34. China Canine Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Japan Canine Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. South Korea Canine Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Southeast Asia Canine Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. India Canine Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Australia Canine Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Canine Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Latin America Canine Cancer Screening Market Share by Country (2019-2030)
 Figure 42. Mexico Canine Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Brazil Canine Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Canine Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Middle East & Africa Canine Cancer Screening Market Share by Country (2019-2030)
 Figure 46. Turkey Canine Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Saudi Arabia Canine Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. UAE Canine Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. IDEXX Revenue Growth Rate in Canine Cancer Screening Business (2019-2024)
 Figure 50. Mars Pedtcare Revenue Growth Rate in Canine Cancer Screening Business (2019-2024)
 Figure 51. Zoetis Revenue Growth Rate in Canine Cancer Screening Business (2019-2024)
 Figure 52. PetDx Revenue Growth Rate in Canine Cancer Screening Business (2019-2024)
 Figure 53. Molecular Diagnostics (MDxHealth) Revenue Growth Rate in Canine Cancer Screening Business (2019-2024)
 Figure 54. Biomérieux SA Revenue Growth Rate in Canine Cancer Screening Business (2019-2024)
 Figure 55. OncoK9 Revenue Growth Rate in Canine Cancer Screening Business (2019-2024)
 Figure 56. Antech Diagnostics Revenue Growth Rate in Canine Cancer Screening Business (2019-2024)
 Figure 57. VolitionRx Limited Revenue Growth Rate in Canine Cancer Screening Business (2019-2024)
 Figure 58. Oncotect Revenue Growth Rate in Canine Cancer Screening Business (2019-2024)
 Figure 59. Heska Corporation Revenue Growth Rate in Canine Cancer Screening Business (2019-2024)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners